Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

SYM S036 - Women’s Health Therapeutic Hotline

Open admission to eligible categories, no tuition or ticket


Date: Monday, March 24

CME Credits: 3.00

Location: Four Seasons Ballroom 4

Time: 9:00 AM - 12:00 PM

Director: Jenny Eileen Murase, MD, FAAD - Handout

  • Whitney A. High, MD, FAAD
  • George Kroumpouzos, MD, PhD, FAAD - Handout
  • Vera H. Price, MD, FAAD
  • Kanade Shinkai, MD, PhD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • Describe a new approach to counseling patients on safety of commonly prescribed dermatologic medications in pregnancy, and recognize the medicolegal implications of prescribing medications in pregnancy.
  • Review hormonal therapies in dermatology for acne and female androgenetic alopecia, focusing on safety concerns.
  • Discuss medical management issues for nursing mothers, including the safety of commonly prescribed dermatologic medications and how to diagnose and treat nipple dermatitis.

This therapeutics symposium highlights issues in women’s health and hormonal therapy in dermatology. We will review a new approach to drug safety in pregnancy, use of cosmetic therapy in pregnancy, and medical malpractice issues in pregnancy. We will also address the appropriate use of hormonal therapy in dermatology: how does one prescribe oral contraceptives safely? Do finasteride and spironolactone improve female pattern androgenetic alopecia? Finally, we will review appropriate medical management of mastitis in breastfeeding mothers and medication safety issues in lactation. This is a practical course filled with therapeutic pearls and counseling tips.


  • Raynaud phenomenon of the nipple in breastfeeding mothers: an underdiagnosed cause of nipple pain. JAMA Dermatol 2013 Mar;149(3):300-6.
  • Caring for new mothers: diagnosis, management and treatment of nipple dermatitis in breastfeeding mothers. Int J Dermatol 2012 Oct;51(10):1149-61.
  • Caution advised in interpretation of US FDA risk classification for dermatological medications during pregnancy. Dermatol Online J 2012 Oct 15;18(10):15.


Monday, March 24
9:00 AMDermatologic medication safety in pregnancy / Dr. Murase
9:30 AMEffect of dermatologic medications on male fertility / Dr. Murase
9:40 AMQ&A / Dr. Murase
9:50 AMMedicolegal implications of prescribing medications in pregnancy / Dr. High
10:10 AMQ&A / Dr. High
10:15 AMCosmetic procedures in pregnancy / Dr. Kroumpouzos
10:30 AMQ&A / Dr. Kroumpouzos
10:35 AMHormonal therapy for acne / Dr. Shinkai
10:55 AMQ&A / Dr. Shinkai
11:00 AMHormonal therapy for alopecia / Dr. Price
11:20 AMQ&A / Dr. Price
11:25 AMMedical management of mastitis in breastfeeding mothers / Dr. Murase
11:50 AMDermatologic medication safety in lactation / Dr. Murase